Meanwhile, NF‐κB and MAPK signaling is closely correlated to the inflammatory response of RA pathogenesis, and new drugs and therapies based on inhibiting NF‐κB and MAPK signaling have been demonstrated to exert a great anti‐inflammatory activity to prevent RA.27, 28, 29. This evidence concerns the gene NFKB1 and rheumatoid arthritis.